BioTech Holding. dk ApS: Financial statements 2020
CVR: 38241672
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BioTech Holding. dk ApS (CVR 38241672) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 100. The solvency ratio was 0.2%.
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 43,605
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 0 | 100 | - |
| 2019 | - | 0 | 0 | 100 | - |
| 2018 | - | 0 | 0 | 100 | - |
| 2017 | 0 | 0 | 0 | 100 | - |
Official annual report
How creditworthy is BioTech Holding. dk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BioTech Holding. dk ApS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK 0.
On May 6, 2020, the company changed its name from SymbiCom Holding IVS to BioTech Holding. dk IVS.
About BioTech Holding. dk ApS
BioTech Holding. dk ApS was a Danish company of the type Anpartsselskab based in Nykøbing Sj, founded in 2016. The company has been dissolved on 21 January 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BioTech Holding. dk IVS and SymbiCom Holding IVS. In 2021, the company reported a gross profit of DKK -2,045 and a net result of DKK -4,029 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 35,971.